Zaltrap Injection, Dosage Form : Liquid

Get Latest Price

Dosage FormLiquid
UsageTreatment Of Metastatic Colorectal Cancer
TypeInjection
ManufacturerSanofi
Supply TypeSupplier
Preferred Buyer Location All over the world

View More Details

Send Enquiry

Company Information

Aarti Drugs Limited

Boisar, Mumbai, Maharashtra

View Number

Member Since 1 Year
Nature of Business Manufacturer
GST No. 27AAACA4410D1ZE

Ask for more detail from the seller

Contact Supplier

Report incorrect details

View Company Details

Product Details
Company Details

ManufacturerSanofi
Storage RequirementsStore In A Refrigerator At 2°C To 8°C (36°F To 46°F)
Dosage FormLiquid
UsageTreatment Of Metastatic Colorectal Cancer
PackagingStandard Medical Packaging
TypeInjection
Administration RouteIntravenous
IndicationMetastatic Colorectal Cancer (mCRC) Resistant To Or Progressed Following An Oxaliplatin-containing Regimen
CombinationFluorouracil, Leucovorin, Irinotecan-(FOLFIRI)

Zaltrap Injection,.

ZALTRAP, in combination with fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.

Interested in this product? Ask for more details & Latest Price from seller

Send Enquiry

Share your requirements for a quick response!